Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Agronomics investee Meatable acquires Uncommon Bio platform

(Sharecast News) - Agronomics said on Friday that its portfolio company Meatable has acquired Uncommon Bio's cultured meat technology platform, strengthening its position in the rapidly developing cellular agriculture sector and expanding its capabilities for commercial-scale production. The AIM-traded firm said the deal included Uncommon's key technology, intellectual property, high-performing cell lines and specialist staff, enabling Meatable to integrate its own patented 'opti-ox' system with Uncommon's non-GMO mRNA reprogramming and saRNA differentiation technologies.

Meatable said the combined platform would accelerate time to market, support regulatory approvals across multiple jurisdictions and broaden product development across species including pork, beef, lamb and poultry.

"With this acquisition, Meatable is reinforcing its position as a global leader in cultivated meat, proving what is possible when the world's sharpest minds address one of our greatest challenges - feeding a growing planet amid rising meat demand and shrinking supply," said Jim Mellon, executive chair of Agronomics.

"By combining Uncommon's platform with its own, Meatable will have an enviable offering for prospective customers, offering greater choice and scalability, and answering the global call for a protein supply chain which can help moderate price volatility, and boost food security."

Uncommon chief executive Benjamina Bollag said the company had chosen to focus on therapeutics and wanted "the best home for our technology."

"It's exciting to see Meatable carry our work forward and apply it at scale," he added.

Meatable chief executive Jeff Tripician said the deal "sets a new standard for cultivated meat production," equipping the company to "reliably deliver high-quality cultivated meat at a global scale."

Agronomics had invested £7.9m in Meatable to date, a position carried at £11.7m as at 30 June, representing about 8.1% of the firm's last reported net asset value.

At 1505 BST, shares in Agronomics were down 0.64% at 7.45p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Botswana Diamonds reports progress in 'difficult year' for industry
(Sharecast News) - Botswana Diamonds reported progress across its exploration portfolio for the year ended 30 June despite what it described as a "very difficult year for the diamond industry", as the AIM-listed company diversified into critical minerals and expanded the use of artificial intelligence in its exploration strategy.
Audioboom reports record monthly performance
(Sharecast News) - Audioboom reported record monthly performance in November on Friday, with revenue reaching a high of $9.1m and gearing strongly to adjusted EBITDA, as the AIM-traded podcast group highlighted accelerating growth in distribution, advertising inventory and video monetisation ahead of its full-year update in January.
Savannah Resources upbeat on new EU raw materials plan
(Sharecast News) - Savannah Resources welcomed further details of the European Commission's RESourceEU Action Plan on Friday, saying the measures could accelerate funding, permitting and market support for critical raw materials projects such as its Barroso lithium development in Portugal.
Gooch & Housego appoints new permanent finance chief
(Sharecast News) - Gooch & Housego announced the appointment of James Corte as its chief financial officer and an executive director on Friday, with his start date expected during the first half of calendar 2026.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.